Mandala Coloring and Music for Cancer Fear and Screening Anxiety

NCT07789236 | Enrolling By Invitation DMC

• 1 other identifier: AICU-KETEM-157-2026
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

Cancer screening is important for detecting cancer at an early stage. However, women attending cancer screening may experience fear of cancer and anxiety related to the screening process. Simple, non-drug approaches that promote relaxation may help reduce these feelings and make the screening experience more comfortable. The purpose of this randomized controlled study is to determine whether a combined mandala coloring and music intervention can reduce cancer fear and anxiety among women attending a Cancer Early Diagnosis, Screening and Training Center (KETEM) for cancer screening. Women aged 30 to 65 years who attend the KETEM unit for their first or routine cancer screening, meet the study eligibility criteria, and agree to participate will be included in the study. Participants will be randomly assigned to one of two groups: an intervention group or a control group. Participants in the intervention group will color a mandala for 20 minutes while listening to slow-tempo instrumental music. The intervention will take place in the KETEM waiting area. Participants in the control group will receive the standard information and routine services provided at KETEM without the mandala coloring and music intervention. Cancer fear and anxiety will be assessed using questionnaires before and after the intervention. The researchers will compare the results between the intervention and control groups to determine whether the combined mandala coloring and music intervention helps reduce cancer fear and anxiety during the cancer screening process. The findings of this study may provide information about whether a simple, low-cost, and non-drug intervention can be used to support women attending cancer screening and make the screening experience less stressful.

Conditions

Cancer Fear and Screening-Related Anxiety in Women Undergoing Cancer Screening

Outcome Measures

Primary Outcomes (3)

• 2. Fear of Cancer Scale (FOCS)

  The Fear of Cancer Scale (FOCS) was developed by Feng and colleagues and the validity and reliability study of the Turkish version was conducted by Öztürk and Kuday. The scale consists of 17 items and two subscales: Direct Fear (items 1, 2, 4, 8, 9, 10, 12, and 13) and Indirect Fear (items 3, 5, 6, 7, 11, 14, 15, 16, and 17). Each item is rated on a 5-point Likert scale ranging from 0 to 4 (0 = Strongly Disagree, 1 = Disagree, 2 = Neither Agree nor Disagree, 3 = Agree, and 4 = Strongly Agree). The total score ranges from 0 to 68, with higher scores indicating greater fear of cancer. The overall Cronbach's alpha coefficient of the scale was reported as 0.920. The Cronbach's alpha coefficients were 0.870 for the Direct Fear subscale and 0.861 for the Indirect Fear subscale.

  Baseline (immediately before the intervention) and immediately after the 30-minute intervention

• 1. Personal Information Form

  The Personal Information Form was developed by the researchers based on the relevant literature and includes questions assessing the participants' sociodemographic characteristics.

  Baseline

• 3. State Anxiety Inventory (STAI-I)

  According to Öner and Le Compte, anxiety can be conceptualized as two distinct forms: state anxiety and trait anxiety. This distinction was initially proposed through the factor-analytic studies of Cattell and Scheier and subsequently formed the basis of the two-factor theory of anxiety developed through the work of Spielberger and colleagues The State-Trait Anxiety Inventory is a self-report instrument consisting of brief statements designed to assess anxiety. Although it was originally developed to assess anxiety among psychiatrically healthy adults, subsequent studies have demonstrated its applicability to high school students as well as individuals with psychiatric and physical health conditions.

  Baseline (immediately before the intervention) and immediately after the 30-minute intervention

Study Arms (3)

1 mandala

EXPERIMENTAL

Participants will receive a 20-minute mandala intervention before the screening procedure.

Other: mandala

3 control

NO INTERVENTION

control

2 musıc

EXPERIMENTAL

Participants will receive a 20-minute music intervention before the screening procedure.

Other: Music

Interventions

mandala OTHER

Participants will receive a 20-minute mandala coloring intervention before the screening procedure.

1 mandala

Music OTHER

\*\*Participants will receive a 20-minute music intervention before the screening procedure.\*\*

2 musıc

Eligibility Criteria

• Age: 18 Years - 65 Years
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being a woman aged 30-65 years.
• \*Applying for cancer screening for the first time or for routine screening.
• Being able to read and write in Turkish.
• Providing voluntary informed consent to participate in the study.

You may not qualify if:

• Having a diagnosed psychiatric disorder.
• Having a hearing impairment severe enough to interfere with the music intervention.
• Having a history of diagnosed cancer.

Sponsors & Collaborators

• Agri Ibrahim Cecen University: lead

Study Sites (1)

Ağrı İbrahim Çeçen University

Ağrı, Ağri, 04100, Turkey (Türkiye)

Location

Related Publications (1)

• Oner N, Le Compte A. Durumluk-Sürekli kaygı envanteri elkitabı, 20. Basım İstanbul: Boğaziçi Üniversitesi Yayınları, 1985. s.3-5.

  BACKGROUND

MeSH Terms

Conditions

Pathophobia

Interventions

Music Therapy

Intervention Hierarchy (Ancestors)

Sensory Art Therapies; Complementary Therapies; Therapeutics; Rehabilitation; Aftercare; Continuity of Patient Care; Patient Care; Psychotherapy; Behavioral Disciplines and Activities

Study Officials

• Nurten OZCALKAP, asisst. prof

  Agri Ibrahim Cecen University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: asisst. prof.

Study Record Dates

• First Submitted: August 23, 2026
• First Posted: August 27, 2026
• Study Start: May 1, 2026
• Primary Completion: August 30, 2026
• Study Completion (Estimated): December 30, 2026
• Last Updated: August 27, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)